Theodore Cieslak

Theodore Cieslak


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2016 in Current Treatment Options in Infectious Diseases
Verified
Journal Article
Closed access
PDF file
TCTheodore Cieslak
Theodore Cieslak
MKMark G Kortepeter
Mark G Kortepeter

6 May 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
DBDavid Brett-Major
David Brett-Major
ESElizabeth R. Schnaubelt
Elizabeth R. Schnaubelt
HCHannah Creager
Hannah Creager
ALAbigail Lowe
Abigail Lowe
TCTheodore Cieslak
Theodore Cieslak
MBM. Jana Broadhurst
M. Jana Broadhurst
The optimal time to initiate research on emergencies is before they occur. However, timely initiation of high-quality research may launch during an emergency under the right conditions. These include an appropriate context, clarity in scientific aims, preexisting resources, strong operational and research structures that are facile, and good governance. Here, Nebraskan rapid research efforts early during the 2020 coronavirus disease pandemic, while participating in the first use of U.S. federal quarantine in 50 years, are described from these aspects, as the global experience with this severe emerging infection grew apace. The experience has lessons in purpose, structure, function, and performance of research in any emergency, when facing any threat.

22 August 2019 in Viruses
Verified
Journal Article
Open access
TCTheodore Cieslak
Theodore Cieslak
JHJocelyn J. Herstein
Jocelyn J. Herstein
MKMark G. Kortepeter
Mark G. Kortepeter
AHAngela L. Hewlett
Angela L. Hewlett
Although the concept of high-level containment care (HLCC or ‘biocontainment’), dates back to 1969, the 2014–2016 outbreak of Ebola virus disease (EVD) brought with it a renewed emphasis on the use of specialized HLCC units in the care of patients with EVD. Employment of these units in the United States and Western Europe resulted in a significant decrease in mortality compared to traditional management in field settings. Moreover, this employment appeared to significantly lessen the risk of nosocomial transmission of disease; no secondary cases occurred among healthcare workers in these units. While many now accept the wisdom of utilizing HLCC units and principles in the management of EVD (and, presumably, of other transmissible and highly hazardous viral hemorrhagic fevers, such as those caused by Marburg and Lassa viruses), no consensus exists regarding additional diseases that might warrant HLCC. We propose here a construct designed to make such determinations for existing and newly discovered diseases. The construct examines infectivity (as measured by the infectious dose needed to infect 50% of a given population (ID50)), communicability (as measured by the reproductive number (R0)), and hazard (as measured by morbidity and mortality). Diseases fulfilling all three criteria (i.e., those that are highly infectious, communicable, and highly hazardous) are considered candidates for HLCC management if they also meet a fourth criterion, namely that they lack effective and available licensed countermeasures.

10 September 2017
Verified
Book Chapter
Closed access
PDF file
AHAngela Hewlett
Angela Hewlett
AVAngela Vasa
Angela Vasa
TCTheodore Cieslak
Theodore Cieslak
JLJohn Lowe
John Lowe
SSShelly Schwedhelm
Shelly Schwedhelm


1 August 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SMSusan McLellan
Susan McLellan
MKMark G. Kortepeter
Mark G. Kortepeter
NBNahid Bhadelia
Nahid Bhadelia
ESErica Shenoy
Erica Shenoy
LSLauren M. Sauer
Lauren M. Sauer
TCTheodore Cieslak
Theodore Cieslak